Advances in Basic and Clinical Aspects of Neurodevelopmental Disorders

15.-16.8.2019 Koko päivä Helsinki Biomedicum, Haartmaninkatu 8, Helsinki

Advances in Basic and Clinical Aspects of Neurodevelopmental Disorders

Registration is open (abstract submission until 28.6.2019): the link is available on the event’s website:

https://www.helsinki.fi/en/conferences/higher-education-research-and-innovation-workshop-eri-w

Wel­come to the Work­shop

“Advances in Basic and Clinical Aspects of Neurodevelopmental Disorders”

Higher Education, Research and Innovation Workshop (ERI-W)

in August 15-16, 2019, Biomedicum Helsinki, Finland

    The presentations on Day 1

  • Frank Kooy, University of Antwerpen, the Netherlands; Clinical development of targeted treatments for fragile X syndrome  
  • Ilario de Toma, Barcelona Institute of Science and Technology, Spain; A transcriptomic approach to conceive new therapies for Down syndrome and its comorbidities
  • Yolanda de Diego Otero, Malaga, Spain; Antioxidants in clinical trials for Fragile X syndrome
  • Pierre Gressens, INSERM, Université Paris Diderot, Paris, France;

Approaches for targeted treatment in neurodevelopmental diseases

  • Mark Daly, FIMM, University of Helsinki, Finland; Genetics of neurodevelopmental disorders
  • Jari Koistinaho, University of Helsinki, Finland; Transcriptomic and proteomic signatures of patient-specific neuronal cells in schizophrenia and psychopathy

    The presentations on Day 2

  • Barbara Bardoni, Inserm, France: Inhibition of PDE2A as therapeutic target for FXS and ASD. 
  • Mahmoud Pouladi, University of Singapore, Singapore; Mechanisms disturbed in triplet repeat diseases
  • Maija Castrén, University of Helsinki, Finland; Human stem cells modelling neurodevelopmental diseases
  • Susanna Narkilahti, Tampere University, Finland; Microarrays for Identification of defective connectivity in brain diseases
  • Laurent Roybon, Lund University, Sweden; Modelling neurodegenerative diseases using iPSCs 
  • Andreas Frick, Inserm, France: Calcium signalling changes in ASD
  • Claudio Rivera, Inserm, Marseille/University of Helsinki, Finland; Chloride transporters in brain diseases
  • Juha Salmitaival, University of Helsinki, Finland; Brain imaging of network dysfunction in autism

 

Poster Session on Day 1 provides an opportunity to present your new data.

City of Helsinki Welcome Reception takes place on Day 1.

 

The organizers of the workshop: 

Maija Castrén, Faculty of Medicine/Physiology, University of Helsinki, Finland, and

Barbara Bardoni, INSERM Institut de Pharmacologie et Cellulaire/CNRS UMR7275, Valbonne, France.

The workshop is supported by the Institut Francais de Finlande, the Embassy of France in Finland, the French Ministry of Higher Education, Research and Innovation, Foundation Jerôme Lejeune, the Doctoral Program Brain & Mind and the Finnish Society of Sciences and Letters.

For program, registration and abstract submission, please visit the workshop website at
www.helsinki.fi/en/conferences/higher-education-research-and-innovation-workshop-eri-w

——-
Katri Wegelius, PhD, Planning Officer
Doctoral Programme Brain & Mind (B&M)
Master’s Programme in Neuroscience (MNEURO)
katri.wegelius@helsinki.fi
+358 (0)50-4480405
www.brain-mind.fi

www.helsinki.fi/master/neuroscience

Katso kaikki